Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

NCT03079544 · clinicaltrials.gov ↗

COMPLETED

Status

665

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK-T-Cell Lymphoma, Nasal Type

Interventions

COMBINATION_PRODUCT: L-Asparaginase or or Pegaspargase containing chemotherapy

Sponsor

Rong Tao